Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.
van den Broek GB, Wildeman M, Rasch CR, Armstrong N, Schuuring E, Begg AC, Looijenga LH, Scheper R, van der Wal JE, Menkema L, van Diest PJ, Balm AJ, van Velthuysen ML, van den Brekel MW. van den Broek GB, et al. Among authors: begg ac. Int J Cancer. 2009 Jun 1;124(11):2643-50. doi: 10.1002/ijc.24254. Int J Cancer. 2009. PMID: 19253368
Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.
Pramana J, Van den Brekel MW, van Velthuysen ML, Wessels LF, Nuyten DS, Hofland I, Atsma D, Pimentel N, Hoebers FJ, Rasch CR, Begg AC. Pramana J, et al. Among authors: begg ac. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1544-52. doi: 10.1016/j.ijrobp.2007.08.032. Epub 2007 Oct 10. Int J Radiat Oncol Biol Phys. 2007. PMID: 17931799 Clinical Trial.
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor.
Hoebers FJ, Pluim D, Hart AA, Verheij M, Balm AJ, Fons G, Rasch CR, Schellens JH, Stalpers LJ, Bartelink H, Begg AC. Hoebers FJ, et al. Among authors: begg ac. Cancer Chemother Pharmacol. 2008 May;61(6):1075-81. doi: 10.1007/s00280-007-0545-1. Epub 2007 Jul 18. Cancer Chemother Pharmacol. 2008. PMID: 17639394 Free PMC article.
CD44 expression predicts local recurrence after radiotherapy in larynx cancer.
de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, Takes RP, Kaanders JH, van der Laan BF, Wachters J, Jansen JC, Rasch CR, van Velthuysen ML, Grénman R, Hoebers FJ, Schuuring E, van den Brekel MW, Begg AC. de Jong MC, et al. Among authors: begg ac. Clin Cancer Res. 2010 Nov 1;16(21):5329-38. doi: 10.1158/1078-0432.CCR-10-0799. Epub 2010 Sep 13. Clin Cancer Res. 2010. PMID: 20837694
Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
de Jong MC, Ten Hoeve JJ, Grénman R, Wessels LF, Kerkhoven R, Te Riele H, van den Brekel MW, Verheij M, Begg AC. de Jong MC, et al. Among authors: begg ac. Clin Cancer Res. 2015 Dec 15;21(24):5630-8. doi: 10.1158/1078-0432.CCR-15-0454. Epub 2015 Aug 11. Clin Cancer Res. 2015. PMID: 26265694
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC. Janssen HL, et al. Among authors: begg ac. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1537-49. doi: 10.1016/s0360-3016(02)03935-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459383
Heterogeneity of gene expression profiles in head and neck cancer.
Pramana J, Pimentel N, Hofland I, Wessels LF, van Velthuysen ML, Atsma D, Rasch CR, van den Brekel MW, Begg AC. Pramana J, et al. Among authors: begg ac. Head Neck. 2007 Dec;29(12):1083-9. doi: 10.1002/hed.20621. Head Neck. 2007. PMID: 17615564
178 results